| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/23/2003 | WO2003006677A2 Multiplex nucleic acid reactions |
| 01/23/2003 | WO2003006675A2 Methods and devices based upon a novel form of nucleic acid duplex on a surface |
| 01/23/2003 | WO2003006672A2 Antimicrobial nucleic acid antibodies, and materials and methods for making and using same |
| 01/23/2003 | WO2003006650A1 Method of purifying nucleic acid using nonwoven fabric and detection method |
| 01/23/2003 | WO2003006646A1 Regulation of human aminopeptidase n |
| 01/23/2003 | WO2003006643A2 A p387l variant in protein tyrosine phosphatase-1b is associated with type 2 diabetes and impaired serine phosphorylation of ptp-1b in vitro |
| 01/23/2003 | WO2003006625A2 Nucleotide compositions comprising photocleavable markers and methods of preparation thereof |
| 01/23/2003 | WO2003006623A2 Directed protein modificaiton by iterative sequence insertion |
| 01/23/2003 | WO2003006614A2 UBE2s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 01/23/2003 | WO2003006612A2 Production of transduced hematopoietic progenitor cells |
| 01/23/2003 | WO2003006611A2 GPCs AS MODIFIERS OF THE IRRTK AND p21 PATHWAYS AND METHODS OF USE |
| 01/23/2003 | WO2003006504A2 Allelic variants of gpr50 |
| 01/23/2003 | WO2003006499A2 Survivin interacting protein tpr1 |
| 01/23/2003 | WO2003006493A2 Histidine phosphatase interacting protein with 180kd |
| 01/23/2003 | WO2003006487A2 Modulation of phosphoinositide 3-kinase activity |
| 01/23/2003 | WO2003006482A2 Use of specific t2r taste receptors to identify compounds that block bitter taste |
| 01/23/2003 | WO2003006471A1 Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands |
| 01/23/2003 | WO2003006103A2 Electrical field stimulation of eukaryotic cells |
| 01/23/2003 | WO2003006076A1 Apparatus for testing sterilization methods and materials |
| 01/23/2003 | WO2003005890A2 Affinity biosensor for monitoring of biological process |
| 01/23/2003 | WO2003005812A2 Modulation of metabolism of steroids and xenobiotics |
| 01/23/2003 | WO2002090578A9 Methods and means of histone methylation |
| 01/23/2003 | WO2002086150A3 Method for detecting a reaction by measuring a pm change |
| 01/23/2003 | WO2002067984A9 Materials and methods for detecting, preventing, and treating hiv and fiv retroviral infection |
| 01/23/2003 | WO2002066978A3 Detection of compounds that modulate inflammatory responses |
| 01/23/2003 | WO2002066975A3 Tissue-based water quality biosensors for detecting chemical warfare agents |
| 01/23/2003 | WO2002055017A3 Method of treating autoimmune diseases |
| 01/23/2003 | WO2002055015A3 Rapid antibiotic susceptibility test |
| 01/23/2003 | WO2002053711A3 Use of transcription factor yb-1 in adenoviral systems |
| 01/23/2003 | WO2002052030A3 Compositions and methods enabling a totally internally controlled amplification reaction |
| 01/23/2003 | WO2002050302A3 Protein-protein interactions |
| 01/23/2003 | WO2002050254A3 Crystal structure of glycogen synthase kinase 3 beta |
| 01/23/2003 | WO2002048388A9 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell |
| 01/23/2003 | WO2002047535A3 High throughput assay to detect inhibitors of the map kinase pathway |
| 01/23/2003 | WO2002046364A9 Genes associated with mechanical stress, expression products therefrom, and uses thereof |
| 01/23/2003 | WO2002045570A3 Methods and compositions for the diagnosis and treatment of viral disease using 55092 |
| 01/23/2003 | WO2002038724A3 A method for the detection of viable microorganisms |
| 01/23/2003 | WO2002036812A9 Nonlinear system identification for class prediction in bioinformatics and related applications |
| 01/23/2003 | WO2002036741A3 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 01/23/2003 | WO2002034948A3 Candidate region mismatch scanning for genotyping and mutation detection |
| 01/23/2003 | WO2002033095A3 Regulation of human serine-threonine protein kinase |
| 01/23/2003 | WO2002031162A3 Regulation of human phospholipase a2-like enzyme |
| 01/23/2003 | WO2002029413A3 An assay for rhabdovirus inhibitors |
| 01/23/2003 | WO2002026834A3 32624 a novel human udp-glucuronosyl and glycosyl transferase family member and uses thereof |
| 01/23/2003 | WO2002024906A9 Induction of exon skipping in eukaryotic cells |
| 01/23/2003 | WO2002022794A3 ENDOTHELIN CONVERTING ENZYMES AND THE AMYLOID βPEPTIDE |
| 01/23/2003 | WO2002018585A3 Packaging of positive-strand rna virus replicon particles |
| 01/23/2003 | WO2002016939A3 Methods of diagnosis of cancer and screening for cancer modulators |
| 01/23/2003 | WO2002016598A3 Nucleic acid and corresponding protein named 158p1h4 useful in the treatment and detection of bladder and other cancers |
| 01/23/2003 | WO2002016553A3 Regulator gene and system useful for the diagnosis and therapy of osteoporosis |
| 01/23/2003 | WO2002010363A3 Protein phosphatases |
| 01/23/2003 | WO2002008415A1 METHOD OF SCREENING PTPz ACTIVITY PROMOTER OR INHIBITOR |
| 01/23/2003 | WO2002008262A3 Bstp-5 proteins and related reagents and methods of use thereof |
| 01/23/2003 | WO2002006513A3 A method for treating herpes viruses |
| 01/23/2003 | WO2002004946A3 Methods for identifying combinations of drugs |
| 01/23/2003 | WO2002004022A9 High fidelity polymerases and uses thereof |
| 01/23/2003 | WO2002000904A3 Recombinant constructs and their use in reducing gene expression |
| 01/23/2003 | WO2001097843A3 Methods for enhancing antibody-induced cell lysis and treating cancer |
| 01/23/2003 | WO2001093851A3 Compositions and methods for treating neoplastic disease using inhibitors of laminin5beta3 |
| 01/23/2003 | WO2001090337A3 Detection of rna |
| 01/23/2003 | WO2001089364A3 Hcv variants |
| 01/23/2003 | WO2001083824A3 Polynucleotide probes for detection and quantitation of candida albicans and candida dubliniensis |
| 01/23/2003 | WO2001083782A3 Novel proteases |
| 01/23/2003 | WO2001077386A3 High-throughput detection of unknown dna mutations by using multiplexed capillary electrophoresis |
| 01/23/2003 | WO2001075174A3 Detection and typing of human papillomavirus using pna probes |
| 01/23/2003 | WO2001075169A3 Compositions and methods for diagnosing, monitoring, staging, imaging and treating stomach cancer |
| 01/23/2003 | WO2001073129A3 Real time monitoring of pcr using loci ('luminiscent oxygen channeling immunoas say technology') |
| 01/23/2003 | WO2001068921A3 Compositions and methods for simultaneous detection of multiple biological entities |
| 01/23/2003 | WO2001063280A3 Inter-alpha-trypsin as a marker for sepsis |
| 01/23/2003 | WO2001061048A3 Methods and compositions for the identification, assessment, prevention and therapy of human cancers |
| 01/23/2003 | WO2001055450A3 AMPLIFIED GENES AT 17q23 |
| 01/23/2003 | WO2001053520A3 Gene chip for neonate screening |
| 01/23/2003 | WO2001048237A9 Method for quickly detecting microbial dna/rna, kit therefor and the use of said method |
| 01/23/2003 | WO2001023606A9 Nucleic acid molecules for detecting bacteria and phylogenetic units of bacteria |
| 01/23/2003 | WO2001007647A9 Method for relative quantization of methylation of cytosin-type bases in dna samples |
| 01/23/2003 | US20030018995 Plants with a modified flower and seed development |
| 01/23/2003 | US20030018987 Animal model for use in the diagnosis and treatment of eating, apoptosis and infectious disorders |
| 01/23/2003 | US20030018349 Nucleic acid molecules specific for bacterial antigens and uses thereof |
| 01/23/2003 | US20030018185 DNA markers useful in genetic analysis( identification of polymorphism and in genome mapping) |
| 01/23/2003 | US20030018180 Secreted protein HFEAF41 |
| 01/23/2003 | US20030018178 Genes encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof |
| 01/23/2003 | US20030018177 Method for nucleic acid isolation and kit |
| 01/23/2003 | US20030018166 Structure of isocitrate lyase enzyme from mycobacterium tuberculosis and inhibitory agents to combat persistent infection |
| 01/23/2003 | US20030018165 Uses of suppressive macrophage activation factors |
| 01/23/2003 | US20030018078 Glaucoma treatments with reduced hyperpigmentation |
| 01/23/2003 | US20030018047 Central nervous system disorders; psychological disorders |
| 01/23/2003 | US20030018007 Compositions and methods for inducing gene expression |
| 01/23/2003 | US20030017991 Substrates and assays for beta-secretase activity |
| 01/23/2003 | US20030017988 Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis |
| 01/23/2003 | US20030017984 Binding to ligand; crystallization; cardiovascular disorders; Alzheimer's disease |
| 01/23/2003 | US20030017982 Genetic engineering; hybrid nucleic acids |
| 01/23/2003 | US20030017981 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030017966 MC4-R as target for the identification of compounds used to treat drug addiction |
| 01/23/2003 | US20030017964 Administration of agents via the PEPT-2 transporter |
| 01/23/2003 | US20030017616 Solid phase for use in the detection of preferential particles in sample |
| 01/23/2003 | US20030017591 Amplification of prferential nucleotide sequences; obtain nucleotide sequences, denature, incubate with primer and polymerase, amplify, recover nucleotide sequences |
| 01/23/2003 | US20030017586 Nucleotide sequences coding polypeptide for use in the treatment of viral diseases |
| 01/23/2003 | US20030017582 Device and method for monitoring leukocyte migration |
| 01/23/2003 | US20030017579 Generation of solid supports; obtain thin film with grooves coated with substrate, expose to biopolymers, allow binding, remove thin film, recover microarray |
| 01/23/2003 | US20030017576 Production of medium chain length polyhydroxyalkanoates from fatty acid biosynthetic pathways |